Fig. 5.
An anti–IL-10R Ab abolishes the effects of SDF-1 on the proliferation and survival of peritoneal B1a lymphocytes.
Proliferation (A) and survival (B) of peritoneal B1a lymphocytes were evaluated using the 5(6) CFDA, SE and DIOC6 (3) labeling assays, respectively. An anti–IL-10R or a control Ab was tested in combination with SDF-1. Results (mean ± SEM) are from 6 experiments (A) and 3 experiments (B). *P < .05 and **P < .005 as compared with cultures with SDF-1 and the control antibody, respectively.
